Contagion&reg Editorial Staff

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Mindy Smith, BSPharm, RPh, shares common misconceptions about the flu shot and how providers can advocate for the vaccination to their patients.

Ellie J. C. Goldstein, MD, discusses the interplay and interchange between long-term and short-term acute care hospitals and explains how transitions in care can result in the spread of antibiotic resistance.

Julie Ann Justo, PharmD, MS, BCPS-AQ ID, explains how rapid diagnostics interplay with prediction scores in antimicrobial stewardship programs.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Colleen Kelley, MD, discusses the importance of keeping all populations on the HIV care continuum, especially those who are at a disadvantage.

Troy Trygstad, PharmD, MBA, PhD, discusses the trends of targeted research in the influenza vaccination space and how protocols could differ based off of variances.

Although the incidence of Chlamydia trachomatis infections remains high among young women (ages 14-24), new data indicate that prevalence of the sexually-transmitted infection is decreasing.

Eric Daar, MD, explains how gene editing therapy can be used to move the HIV cure agenda forward.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The FDA has approved 2 new treatments for HIV: a once-daily fixed-dose combination tablet of doravirine, lamivudine, and tenofovir disoproxil fumarate; and doravirine, a new NNRTI to be administered in combination with other antiretroviral medicines.

Nimish Patel, PharmD, PhD, discusses the updates to CDI management guidelines and the role of the pharmacists in providing education to physicians.

Additional evidence supports the use of oritavancin as a cost-saving outpatient treatment for acute bacterial skin and skin structure infections (ABSSTIs) in patients who would otherwise be admitted to the hospital for therapy.

Jason Gallagher, PharmD, discusses the clinical implications of eravacycline for the treatment of intra-abdominal infections.

The FDA has approved eravacycline (XERAVA) for the treatment of complicated intra-abdominal infections.

New recommendations from the CDC's Advisory Committee on Immunization Practices reveal that health care providers have the intranasally-administered live attenuated influenza vaccine (LAIV) among their arsenal of available vaccines for the 2018-2019 flu season.

Bruce Jones, PharmD, BCPS, discusses the growing burden of ABSSSI and why there have been an influx of MRSA cases.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Colleen Kelley, MD, the biggest barriers to HIV prevention methods and how to overcome them.

Barbara Wells Trautner, MD, PhD, explains the difference between asymptomatic bacteriuria and urinary tract infections.

Ellie J. C. Goldstein, MD, discusses the global threat of resistant gram-negative rods and recently approved drugs ceftolozane tazobactam and ceftazidime avibactam.

We’re rounded up a list of recalls issued by the US Food and Drug Administration (FDA) from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Yoav Golan, MD, discusses trends in the incidence of acute bacterial skin and skin structure infections, standard protocols for treatment, and the challenges clinicians continue to face.

Julie Ann Justo, PharmD, MS, BCPS-AQ ID, provides an example of how institution-specific information can be used to generate a customized risk score.

We’re rounded up a list of recalls issued by the US Food and Drug Administration (FDA) from this past week.

Barbara Wells Trautner, MD, PhD, discusses finding alternatives to fluoroquinolones and facilitating patient communication to improve outcomes.